Portfolio Diversification
Range
Most Diversified
20 instruments
July 7, 2023
Least Diversified
10 instruments
July 1, 2025
Average
18 instruments
Most Consistent Holdings
Top 5
MRK100%
ROG.ZU100%
BDX100%
AZN.L100%
DXCM100%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Eli Lilly (LLY) | 11.89% | 2.41% | 99.63% | - |
 Novo-Nordisk (NVO) | 9.21% | 3% | 100% | - |
| Merck (MRK) | 9.2% | 5.84% | 100% | - |
| AstraZeneca (AZN.L) | 6.47% | 5.54% | 100% | - |
 Abbott (ABT) | 6.31% | 4.92% | 99.93% | - |
| DexCom (DXCM) | 5.43% | 5.2% | 100% | - |
 Medtronic (MDT.US) | 4.9% | 5.35% | 99.93% | - |
 Insulet (PODD) | 4.32% | 6.4% | 100% | - |
 Sanofi (SAN.PA) | 3.93% | 1.72% | 99.93% | - |
| Roche (ROG.ZU) | 3.88% | 4.1% | 100% | - |
 Johnson & Johnson (JNJ) | 3.74% | 6.77% | 69.59% | - |
| BD (BDX) | 3.65% | 3.76% | 100% | - |
 Tandem Diabetes (TNDM) | 2.85% | 0.43% | 99.93% | - |
 Bristol-Myers Squibb (BMY) | 2.79% | 3.25% | 61.25% | - |
 Bayer (BAYN.DE) | 2.63% | 0% | 51.88% | 1/3/2024 |
 Neurocrine Biosciences (NBIX) | 2.41% | 4.94% | 47.75% | - |
 Ascendis Pharma (ASND) | 2.39% | 6.3% | 47.97% | - |
 Halozyme (HALO) | 2.22% | 5.09% | 45.76% | - |
 Alkermes (ALKS) | 2.2% | 4.36% | 47.82% | - |
 MannKind (MNKD) | 2.18% | 3.55% | 64.35% | - |
 Rhythm Pharmaceuticals (RYTM) | 1.39% | 0% | 27.16% | 1/8/2025 |
 Almirall (ALM.MC) | 1.17% | 0% | 51.88% | 1/3/2024 |
 GlaxoSmithKline (GSK) | 1.12% | 0% | 27.16% | 1/8/2025 |
 Pfizer (PFE) | 0.99% | 4.65% | 20.66% | - |
 Sandoz (SDZNY) | 0.67% | 0% | 15.42% | 8/1/2024 |
 GSK (GSK.L) | 0.5% | 0% | 13.06% | 1/3/2024 |
 Lexicon Pharmaceuticals (LXRX) | 0.29% | 0% | 13.14% | 1/3/2024 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
| Instrument | Invested | Value |
|---|---|---|
| Insulet (PODD) | 7.29% | 8% |
| Rhythm Pharmaceuticals (RYTM) | 5.18% | 6.48% |
| Bristol-Myers Squibb (BMY) | 6.58% | 6.19% |
| Johnson & Johnson (JNJ) | 6.93% | 6.11% |
| Eli Lilly (LLY) | 2.07% | 5.63% |
| Alkermes (ALKS) | 5.57% | 5.59% |
| Medtronic (MDT.US) | 6.52% | 5.28% |
| Neurocrine Biosciences (NBIX) | 5.22% | 5.26% |
| Abbott (ABT) | 5.49% | 5.19% |
| Ascendis Pharma (ASND) | 4.66% | 4.97% |
| Halozyme (HALO) | 5.61% | 4.76% |
| BD (BDX) | 5.19% | 4.51% |
| Merck (MRK) | 3.88% | 4.48% |
| DexCom (DXCM) | 6.5% | 4.43% |
| Roche (ROG.ZU) | 5.55% | 4.24% |
| Sanofi (SAN.PA) | 4.54% | 4.23% |
| AstraZeneca (AZN.L) | 4.18% | 4.18% |
| Tandem Diabetes (TNDM) | 2.56% | 3.68% |
| GlaxoSmithKline (GSK) | 4.08% | 3.52% |
| Novo-Nordisk (NVO) | 1.74% | 2.62% |